Literature DB >> 32376620

Lactoferrin-Hexon Interactions Mediate CAR-Independent Adenovirus Infection of Human Respiratory Cells.

B David Persson1, Annasara Lenman1,2, Lars Frängsmyr1, Markus Schmid3, Clas Ahlm1, Andreas Plückthun3, Håvard Jenssen4, Niklas Arnberg5.   

Abstract

Virus entry into host cells is a complex process that is largely regulated by access to specific cellular receptors. Human adenoviruses (HAdVs) and many other viruses use cell adhesion molecules such as the coxsackievirus and adenovirus receptor (CAR) for attachment to and entry into target cells. These molecules are rarely expressed on the apical side of polarized epithelial cells, which raises the question of how adenoviruses-and other viruses that engage cell adhesion molecules-enter polarized cells from the apical side to initiate infection. We have previously shown that species C HAdVs utilize lactoferrin-a common innate immune component secreted to respiratory mucosa-for infection via unknown mechanisms. Using a series of biochemical, cellular, and molecular biology approaches, we mapped this effect to the proteolytically cleavable, positively charged, N-terminal 49 residues of human lactoferrin (hLF) known as human lactoferricin (hLfcin). Lactoferricin (Lfcin) binds to the hexon protein on the viral capsid and anchors the virus to an unknown receptor structure of target cells, resulting in infection. These findings suggest that HAdVs use distinct cell entry mechanisms at different stages of infection. To initiate infection, entry is likely to occur at the apical side of polarized epithelial cells, largely by means of hLF and hLfcin bridging HAdV capsids via hexons to as-yet-unknown receptors; when infection is established, progeny virions released from the basolateral side enter neighboring cells by means of hLF/hLfcin and CAR in parallel.IMPORTANCE Many viruses enter target cells using cell adhesion molecules as receptors. Paradoxically, these molecules are abundant on the lateral and basolateral side of intact, polarized, epithelial target cells, but absent on the apical side that must be penetrated by incoming viruses to initiate infection. Our study provides a model whereby viruses use different mechanisms to infect polarized epithelial cells depending on which side of the cell-apical or lateral/basolateral-is attacked. This study may also be useful to understand the biology of other viruses that use cell adhesion molecules as receptors.
Copyright © 2020 Persson et al.

Entities:  

Keywords:  CAR; adenovirus; cellular receptor; lactoferrin; tropism

Year:  2020        PMID: 32376620     DOI: 10.1128/JVI.00542-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  5 in total

1.  Transcriptome Analysis of Genes Responding to Infection of Leghorn Male Hepatocellular Cells With Fowl Adenovirus Serotype 4.

Authors:  Xueping P Wang; Bo Wen; Xiao J Zhang; Lei Ma; Xiu L Liang; Ming L Zhang
Journal:  Front Vet Sci       Date:  2022-06-14

Review 2.  Adenovirus-Extracellular Protein Interactions and Their Impact on Innate Immune Responses by Human Mononuclear Phagocytes.

Authors:  Coraline Chéneau; Eric J Kremer
Journal:  Viruses       Date:  2020-11-26       Impact factor: 5.048

3.  The structure of enteric human adenovirus 41-A leading cause of diarrhea in children.

Authors:  K Rafie; A Lenman; J Fuchs; A Rajan; N Arnberg; L-A Carlson
Journal:  Sci Adv       Date:  2021-01-08       Impact factor: 14.136

4.  Defensin-driven viral evolution.

Authors:  Karina Diaz; Ciara T Hu; Youngmee Sul; Beth A Bromme; Nicolle D Myers; Ksenia V Skorohodova; Anshu P Gounder; Jason G Smith
Journal:  PLoS Pathog       Date:  2020-11-24       Impact factor: 6.823

5.  Lactoferrin Retargets Human Adenoviruses to TLR4 to Induce an Abortive NLRP3-Associated Pyroptotic Response in Human Phagocytes.

Authors:  Coraline Chéneau; Karsten Eichholz; Tuan Hiep Tran; Thi Thu Phuong Tran; Océane Paris; Corinne Henriquet; Jeffrey J Bajramovic; Martine Pugniere; Eric J Kremer
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.